Raras
Buscar doenças, sintomas, genes...
Síndrome de parkinsonismo – espasticidade, ligada ao cromossomo X
ORPHA:363654CID-10 · G20OMIM 300911PCDT · SUSDOENÇA RARA

A síndrome de parkinsonismo-espasticidade ligada ao cromossomo X é uma doença neurológica genética rara, caracterizada por sinais e sintomas semelhantes aos do Parkinson. Estes incluem tremores em repouso ou ao fazer movimentos, rigidez muscular (como uma "roda dentada", com interrupções ao mover um membro), pouca expressão facial (hipomimia) e lentidão dos movimentos (bradicinesia). Além disso, está associada a espasticidade (rigidez muscular constante e involuntária) que se manifesta de forma e intensidade variáveis em cada pessoa, reflexos tendinosos profundos exagerados e o sinal de Babinski.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de parkinsonismo-espasticidade ligada ao cromossomo X é uma doença neurológica genética rara, caracterizada por sinais e sintomas semelhantes aos do Parkinson. Estes incluem tremores em repouso ou ao fazer movimentos, rigidez muscular (como uma "roda dentada", com interrupções ao mover um membro), pouca expressão facial (hipomimia) e lentidão dos movimentos (bradicinesia). Além disso, está associada a espasticidade (rigidez muscular constante e involuntária) que se manifesta de forma e intensidade variáveis em cada pessoa, reflexos tendinosos profundos exagerados e o sinal de Babinski.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
5
pacientes catalogados
Início
Adolescent
+ adult
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G20
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
5 sintomas
😀
Face
1 sintomas

+ 16 sintomas em outras categorias

Características mais comuns

100%prev.
Espasticidade
Frequente (79-30%)
100%prev.
Tremor de repouso
Muito frequente (99-80%)
100%prev.
Rigidez em roda denteada
Muito frequente (99-80%)
100%prev.
Parkinsonismo
Frequência: 5/5
80%prev.
Bradicinesia
Frequente (79-30%)
80%prev.
Face hipomímica
Frequência: 4/5
22sintomas
Muito frequente (6)
Frequente (4)
Ocasional (10)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 22 características clínicas mais associadas, ordenadas por frequência.

EspasticidadeSpasticity
Frequente (79-30%)100%
Tremor de repousoResting tremor
Muito frequente (99-80%)100%
Rigidez em roda denteadaCogwheel rigidity
Muito frequente (99-80%)100%
ParkinsonismoParkinsonism
Frequência: 5/5100%
BradicinesiaBradykinesia
Frequente (79-30%)80%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2026127 papers
Linha do tempo
2026Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.

ATP6AP2Renin receptorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Multifunctional protein which functions as a renin, prorenin cellular receptor and is involved in the assembly of the lysosomal proton-transporting V-type ATPase (V-ATPase) and the acidification of the endo-lysosomal system (PubMed:12045255, PubMed:29127204, PubMed:30374053, PubMed:32276428). May mediate renin-dependent cellular responses by activating ERK1 and ERK2 (PubMed:12045255). By increasing the catalytic efficiency of renin in AGT/angiotensinogen conversion to angiotensin I, may also pla

LOCALIZAÇÃO

Endoplasmic reticulum membraneLysosome membraneCytoplasmic vesicle, autophagosome membraneCell projection, dendritic spine membraneCell projection, axonEndosome membraneCytoplasmic vesicle, clathrin-coated vesicle membraneCytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane

VIAS BIOLÓGICAS (2)
Metabolism of Angiotensinogen to AngiotensinsNeutrophil degranulation
MECANISMO DE DOENÇA

Intellectual developmental disorder, X-linked, syndromic, Hedera type

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSH patients manifest mild to moderate intellectual disability associated with epilepsy, delays in motor milestones and speech acquisition in infancy.

OUTRAS DOENÇAS (3)
syndromic X-linked intellectual disability Hedera typeX-linked parkinsonism-spasticity syndromecongenital disorder of glycosylation, type IIr
HGNC:18305UniProt:O75787

Variantes genéticas (ClinVar)

196 variantes patogênicas registradas no ClinVar.

🧬 ATP6AP2: GRCh38/hg38 Xp22.33-11.4(chrX:251888-42476276)x2 ()
🧬 ATP6AP2: NM_005765.3(ATP6AP2):c.30G>T (p.Leu10Phe) ()
🧬 ATP6AP2: NM_005765.3(ATP6AP2):c.588G>A (p.Leu196=) ()
🧬 ATP6AP2: NM_005765.3(ATP6AP2):c.211C>T (p.Arg71Cys) ()
🧬 ATP6AP2: NM_005765.3(ATP6AP2):c.238G>C (p.Val80Leu) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 5 variantes classificadas pelo ClinVar.

3
2
Patogênica (60.0%)
Benigna (40.0%)
VARIANTES MAIS SIGNIFICATIVAS
ATP6AP2: NM_005765.3(ATP6AP2):c.858G>A (p.Ala286=) [Conflicting classifications of pathogenicity]
ATP6AP2: NM_005765.3(ATP6AP2):c.490G>A (p.Val164Ile) [Conflicting classifications of pathogenicity]
ATP6AP2: NM_005765.3(ATP6AP2):c.345C>T (p.Ser115=) [Pathogenic]
ATP6AP2: NM_005765.3(ATP6AP2):c.1050T>C (p.Asp350=) [Benign/Likely benign]
ATP6AP2: NM_005765.3(ATP6AP2):c.38-5T>C [Benign/Likely benign]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de parkinsonismo – espasticidade, ligada ao cromossomo X

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Second allogeneic stem cell transplantation for XMEN disease.

BMJ case reports2026 Mar 23

X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia (XMEN) disease is due to an inherited defect in immunity from loss-of-function mutations in the magnesium transporter 1 gene (MAGT1). Patients can present as adults with XMEN disease from a delayed diagnosis or lack of genetic diagnosis. Allogeneic stem-cell transplantation is curative in XMEN disease, but the mortality is high, especially in adults. Defective N-glycosylation of platelet glycoproteins impairs platelet aggregation and risks fatal mucosal haemorrhage (such as posterior epistaxis with airway obstruction and haemorrhagic shock requiring intubation) early during post-transplant aplasia. Maintaining a platelet level of at least 30×109/L until engraftment could avoid life-threatening haemorrhage. This is the first report of a successful second allogeneic stem-cell transplant in XMEN disease. Allogeneic stem-cell transplant in adults with XMEN disease should be considered as a curative option in patients with suitable donors.

#2

Systematic reassessment of reported variants in individuals with suspicion of Alport spectrum disorder reveals a high rate of ambiguous results.

European journal of human genetics : EJHG2026 Mar 18

"Alport spectrum disorder" describes a phenotypically and genotypically multifaceted disease entity encompassing classic autosomal recessive and X-linked Alport syndrome (AS) but also more heterogenous and typically milder, yet not benign, hematuric phenotypes like autosomal dominant AS, formerly also known as thin basement membrane nephropathy (TBMN). Alport spectrum disorder is associated with disease-causing variants in the type IV collagen genes COL4A3, COL4A4 and COL4A5. Variants and genotypes, reported by a genetic diagnostics lab between 2009 and 2014, of 91 index cases with the clinical tentative diagnosis of AS (66/91), TBMN (21/91), or AS/TBMN (not specified further; 4/91), were reassessed based on 2015 ACMG (American College of Medical Genetics and Genomics) criteria and current amendments. 80 different variants, all originally reported as "mutations", and their genotypes have been reassessed (COL4A3: 21/80, COL4A4: 15/80, COL4A5: 44/80). In 10/80 variants, classification changed from disease-causing to variant of uncertain significance (VUS). 69/91 (76%) index cases included in the analysis could be classified as solved. 22/91 (24%) index cases had an ambiguous result either on variant, genotype, or both variant and genotype level. VUS cases had a significantly more limited phenotype (e.g., isolated microscopic hematuria) compared to non-downgraded cases (e.g., additional extrarenal manifestations). Reassessment of variants/genotypes in this study showed a significant reduction in unequivocal genetic diagnoses highlighting variant and genotype interpretation as a dynamic process. Genetic reports of individuals with suspected Alport spectrum disorder, especially those obtained in the pre-ACMG criteria era, should therefore be critically evaluated.

#3

Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes.

iScience2026 Mar 20

Barth syndrome, a rare X-linked genetic disorder, features early-onset cardiomyopathy. The causal gene, TAFAZZIN, encodes a transacylase that mediates the acyl chain remodeling of cardiolipin, a critical phospholipid in the inner mitochondrial membrane. While Barth syndrome exhibits hallmark cardiolipin abnormalities, the precise mechanisms linking TAFAZZIN deficiency and disturbed cardiolipin metabolism to progressive cardiac dysfunction remain unclear. In this study, we modeled Barth syndrome cardiomyopathy in human induced pluripotent stem cell-derived cardiomyocytes with in vitro maturation treatments that simulate heart developmental stimuli. We found that cardiomyocyte maturation involves progressive cristae dynamics associated with protein and lipid alterations in the inner mitochondrial membrane. TAFAZZIN-deficient cardiomyocytes fail to adapt to the developmental stimuli, resulting in damaged cristae, compromised mitochondrial respiration, and cardiomyocyte dysfunction. These results demonstrate that TAFAZZIN deficiency perturbs functional and structural development of mitochondria, which may contribute to mitochondrial dysfunction and associated childhood progression to cardiomyopathy in Barth syndrome.

#4

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.

Molecular therapy : the journal of the American Society of Gene Therapy2026 Mar 13

FOXP3 is an essential transcription factor driving lineage commitment and function of regulatory T cells (Treg). We previously reported a proof-of-concept study describing engineered Treg (EngTreg) generated using HDR-based editing of the FOXP3 gene in CD4+ T cells, resulting in constitutive, high level endogenous FOXP3 expression leading to acquisition of a Treg phenotype and robust in vitro and in vivo suppressive function. Here, we expand this gene editing strategy to integrate a functional FOXP3 cDNA to enable EngTreg therapy for immune dysregulation, poly-endocrinopathy, enteropathy, X-linked syndrome (IPEX), a devastating multiorgan autoimmune disorder mediated by mutations within the FOXP3 gene. We provide detailed characterization of pre-clinical EngTreg generation including gene targeting efficiencies, cell enrichment and expansion, analyses of potential off target editing, and phenotypic and functional characterization including in vitro suppression of effector T cells and in vivo reversal of GvHD. Importantly, in parallel, we utilize syngeneic and humanized mouse models to demonstrate the safety of EngTreg in primary and secondary humoral responses and viral infection control, respectively. Our combined pre-clinical dataset strongly supports efficacy and safety of EngTreg as a promising potential cellular therapeutic approach for IPEX and, possibly, other autoimmune disorders.

#5

Cerebellar hypoplasia caused by CASK deficiency.

Molecules and cells2026 Mar 12

Calcium/calmodulin-dependent serine protein kinase (CASK) is an X-linked multidomain scaffolding protein originally identified as an intracellular binding partner for Neurexins, a family of presynaptic cell-adhesion molecules. Loss-of-function mutations in CASK cause microcephaly with pontine and cerebellar hypoplasia (MICPCH), a severe neurodevelopmental disorder predominantly affecting females. Although CASK has been implicated in synaptic organization and transcriptional regulation, the mechanisms underlying the cerebellar hypoplasia have remained unsolved. Recent studies using genetically engineered mouse models and cerebellar granule cell cultures suggest that CASK is essential for neuronal survival rather than for initial patterning in cerebellum. These works further reveal that X-chromosome inactivation-driven mosaicism influences the pathology of this disorder and that CASK deficiency activates c-Jun N-terminal kinase (JNK) signaling. In this review, we integrate these findings with the synaptic cell-adhesion biology, in relevance to Neurexin-CASK interaction, and role of CASK in cerebellar neuron survival, and discuss emerging therapeutic implications for CASK-related disorders.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

The selective 5-HT1A receptor biased agonist, NLX-101, corrects anomalous behavioral phenotype in a mouse model of fragile X syndrome.

Progress in neuro-psychopharmacology &amp; biological psychiatry
2026

Second allogeneic stem cell transplantation for XMEN disease.

BMJ case reports
2026

VEXAS syndrome in adults: A narrative review of genomic pathogenesis, multisystem phenotypes, diagnostic algorithms, and emerging therapeutic strategies.

Autoimmunity reviews
2026

Electroencephalography signals in a female Fragile X Syndrome mouse model.

NeuroImage
2026

Laparoscopic transabdominal pre-peritoneal hernia repair with bilateral orchidectomy in partial androgen insensitivity syndrome.

Journal of minimal access surgery
2026

Danon Disease Diagnosed by Multimodal Imaging.

JACC. Case reports
2026

Case report: a case of CYBB gene variant in X-linked chronic granulomatous disease.

BMC pediatrics
2026

Systematic reassessment of reported variants in individuals with suspicion of Alport spectrum disorder reveals a high rate of ambiguous results.

European journal of human genetics : EJHG
2026

VEXAS Syndrome with an Improvement of Chest Shadows Without Immunosuppressive Therapy: A Case Report.

Internal medicine (Tokyo, Japan)
2025

Coexisting genetic kidney disease explains many cases of 'familial' IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits.

Frontiers in medicine
2026

Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes.

iScience
2026

A Novel MID1 Mutation Identified in a Patient With Craniofacial Anomalies and X-Linked Intellectual Disability.

The Journal of craniofacial surgery
2026

Deficient Cardiolipin Remodelling Alters Muscle Fibre Composition and Neuromuscular Connectivity in Barth Syndrome.

Journal of cachexia, sarcopenia and muscle
2026

Retarded DNA DSB repair kinetics and augmented radiation sensitivity in Wiskott Aldrich syndrome patients.

Scientific reports
2026

OTUD5-related rare X-linked multiple congenital anomalies and neurodevelopmental syndrome: clinical findings and review of the literature.

Neurogenetics
2026

Cleft Lip and Palate is Common in PORCN-Related Focal Dermal Hypoplasia in Asians: Three New Case Reports and Literature Review.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2026

Implications of Glomus Tumor Pathology and Pain Mechanism for Surgical Treatment.

Annali italiani di chirurgia
2026

A novel KDM6A c.2429dup mutation causing kabuki syndrome type 2 identified in a fetus with increased nuchal translucency.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.

Molecular therapy : the journal of the American Society of Gene Therapy
2026

Cerebellar hypoplasia caused by CASK deficiency.

Molecules and cells
2026

A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization.

International journal of molecular sciences
2026

Effects of Cannabidiol on TAFAZZIN-Deficient B-Lymphoblastoid Cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Large-Vessel Vasculitis With Autoimmune Myelodysplastic Syndrome: An Uncommon Case of Large-Vessel Vasculitis With Cytopenia That Is Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome (VEXAS) Negative.

Cureus
2026

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12-Related Developmental Disorders.

American journal of medical genetics. Part A
2026

Dysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.

Frontiers in molecular neuroscience
2026

A hierarchical gene-hormone model of cognitive circuit development in Turner Syndrome (45,X).

Neuroscience and biobehavioral reviews
2025

[Application of SNP linkage-based PGT-M to block the transmission of EFNB1 deletion in a Chinese family affected with Cranio-facial-nasal syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

A novel heterozygous pathogenic variation in the MECP2 gene causing typical Rett syndrome: a case report.

Translational pediatrics
2026

Heterozygous X-linked Alport syndrome in a pregnant woman: A case report.

SAGE open medical case reports
2026

Nonextraction solution for self-injurious behavior in children with Lesch-Nyhan syndrome: a retrospective case series with up to 14 years of follow-up.

Quintessence international (Berlin, Germany : 1985)
2026

Development of an integrative cross-omics approach for conceptual adverse outcome pathway network construction.

Environment international
2026

A patient with WHIM syndrome presenting relatively low TREC, KREC, and housekeeping gene levels by newborn screening -a case report and the literature review.

Immunological medicine
2026

PRPS1 (p.V42L) Mutation in Arts Syndrome Induces Aberrant Neural Stem Cell Development and Neuronal Senescence-Like Phenotype: Rescue by Nicotinamide Mononucleotide Supplementation.

International journal of stem cells
2026

Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.

Expert review of clinical immunology
2026

SPIN4-related X-linked overgrowth in a family.

European journal of medical genetics
2026

Case Report: Deletion in the 5' untranslated region of TAFAZZIN in a boy with Barth syndrome.

Frontiers in cardiovascular medicine
2026

Alport syndrome complicated with IgA nephropathy: a case report.

Frontiers in medicine
2026

Genetic Basis and Heterogeneity of Congenital Hypogonadotropic Hypogonadism.

Seminars in reproductive medicine
2026

Multifactorial Predictors of Renal Outcomes in Alport Syndrome: Integrating Genetic, Clinical, and Cystic Phenotypes.

Kidney medicine
2026

The Inheritance Puzzle: A Case of Dual Genetic Kidney Disease.

Nephrology (Carlton, Vic.)
2026

A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes.

Immunity, inflammation and disease
2026

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.

Journal of clinical medicine
2026

Foundations of an Ovine Model of Fragile X Syndrome.

Genes
2026

Otopalatodigital Syndrome Type 2: A Case Report.

Neonatal network : NN
2026

Steroid Sulfatase Deficiency: Clinical Manifestations and Psychological Aspects in Light of Current Evidence.

Clinical, cosmetic and investigational dermatology
2026

Emerging role of KDM5C in X-linked intellectual disability based on human genetic data and zebrafish models.

Frontiers in molecular neuroscience
2026

Orofacial clefting in PHF6-related Börjeson-Forssman-Lehmann syndrome.

BMJ case reports
2026

Airway Involvement in Conradi-Hünermann-Happle Syndrome: A Novel Clinical Manifestation.

The Laryngoscope
2026

Navigating through uncertainty-Experience from the UK national VEXAS MDT.

British journal of haematology
2026

Immune Dysregulation, Polyendocrinopathy and Enteropathy X-Linked Syndrome with Neonatal Onset: A Case Report.

Acta medica portuguesa
2026

Case Report: A female case of X-linked intellectual disability syndrome type 34 caused by a NONO frameshift variant and literature review.

Frontiers in pediatrics
2026

Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors.

Cancer reports (Hoboken, N.J.)
2026

Altered Brain Structure in an ATRX-Deficient Mouse Model of Autism Spectrum Disorder.

Autism research : official journal of the International Society for Autism Research
2026

A Cohort Study of 38 Classic Wiskott-Aldrich Syndrome Cases with Six Novel Mutations.

Journal of clinical immunology
2026

Proteomic dataset of MECP2-deficient and wild-type human brain organoids under spaceflight and ground conditions.

Scientific data
2026

Case Report: Early-onset VEXAS syndrome with recurrent pulmonary inflammation and myelodysplasia: a diagnostic and therapeutic challenge.

Frontiers in immunology
2026

Keipert syndrome beyond classical features: novel GPC4 variant associated with epilepsy but preserved cognition.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

NONO-Related Syndromic X-Linked Developmental Disability 34: Further Clinical and Molecular Delineation in a Prenatal Cohort.

Prenatal diagnosis
2026

Expanding the Clinical Spectrum of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: The First Report of Histologically Confirmed Neutrophilic Colitis With Rare Muscular and Pancreatic Involvement.

Cureus
2026

Good's Syndrome Mirrors a Combined Immunodeficiency with Anti-Cytokine Antibodies in the Total Absence of B Cells.

Journal of clinical immunology
2026

The Nodding syndrome cerebrospinal fluid proteome: a lens into neurodevelopmental failure consistent with environmentally triggered MECP2 dysregulation?

Frontiers in molecular neuroscience
2026

Osteopathia striata with cranial sclerosis, associated with juvenile idiopathic arthritis: A case report and review of literature.

World journal of orthopedics
2026

Börjeson-Forssman-Lehmann Syndrome in a Pediatric Patient: A Four-Year Longitudinal Case Report Focused on Functional Evolution and Rehabilitation.

Cureus
2026

A novel NMD-escaping STAG2 variant associated with syndromic neurodevelopmental delay, growth failure, and distinctive dysmorphism: expanding the phenotype in male patients and literature review.

Gene
2026

Abnormal iron homeostasis mediates cochlear hair cell impairment and hearing loss in Gprasp2-deficient mice.

Communications biology
2026

Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.

Molecular genetics and metabolism
2026

Twins With Pathogenic RNF113A Variant Presenting With Testicular Regression Syndrome.

JCEM case reports
2026

Hereditary Myopathy With Early Respiratory Failure Associated With an Incidental COL4A5 Variant: A Case Report.

Case reports in genetics
2026

WAS Protein Deficiency Disrupts Memory B Cell Formation During Acute LCMV Infection.

Journal of clinical immunology
2026

[Phenotypic heterogeneity and management strategies for two brothers with XIAP deficiency syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Transcranial Photobiomodulation in Rett Syndrome: A Mechanistic Review and Therapeutic Hypothesis.

Photobiomodulation, photomedicine, and laser surgery
2026

The Importance of a Multidisciplinary Team Approach in a Rare Case of Antenatally Diagnosed Tonne-Kalscheuer Syndrome.

Cureus
2026

Case Report: Neuroretinitis versus hypertensive retinopathy secondary to Alport syndrome.

Frontiers in neurology
2026

Behavioral Phenotype Associations With Resting State EEG Signal Complexity and Power Spectral Density in Fragile X Syndrome.

Autism research : official journal of the International Society for Autism Research
2026

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.

Journal of clinical immunology
2025

Genetic diagnosis of three intellectually disabled individuals in a pedigree and insights into fragile X syndrome diagnosis.

Frontiers in neuroscience
2026

mRNA Therapy for Alport Syndrome.

bioRxiv : the preprint server for biology
2026

KCC2 Activation Reverses Neurophysiological and Behavioral Deficits in Female Rett Mice.

bioRxiv : the preprint server for biology
2026

Enamel renal syndrome due to FAM20A mutations: challenging kidney management in view of nephrocalcinosis, hypophosphatemia and hypocalciuria.

Orphanet journal of rare diseases
2026

Disease-modifying therapies for Rett syndrome: a review for neurologists.

Frontiers in neurology
2026

[Chinese expert consensus on the diagnosis and treatment of Becker muscular dystrophy].

Zhonghua nei ke za zhi
2025

Rheumatology 2050: How our specialty is changing.

Future healthcare journal
2026

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus
2026

A fatal case of VEXAS syndrome with a brief review.

Journal of vascular surgery cases and innovative techniques
2026

Case Reviews for Two Families With Unique Variants in TBX22 Causing Abruzzo-Erickson Syndrome.

American journal of medical genetics. Part A
2025

Unmasking Wiskott-Aldrich Syndrome in Adulthood in a Case of Long-Standing Bleeding, Infections, and Steroid-Induced Morbidity.

Cureus
2025

Diagnostic Utility of Optical Genome Mapping in X-Linked Dominant Genodermatoses: Incontinentia Pigmenti and CHILD Syndrome.

Molecular syndromology
2026

Prenatal diagnosis of distal Xq28 duplication syndrome: case reports and literature review.

Molecular cytogenetics
2026

Profiling metabotropic glutamate receptor 7 expression in Rett syndrome: consequences for pharmacotherapy.

Neuroscience
2026

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

Seminars in arthritis and rheumatism
2026

Developmental and Epileptic Encephalopathy due to Cyclin-Dependent Kinase-Like 5 Deficiency: A Single-Center Experience Across Sex Differences.

Pediatric neurology
2026

Addressing the unmet challenge of pain in rare bone diseases: new insights from the RUDY UK registry.

Orphanet journal of rare diseases
2026

COVID-19 Outcomes and Risk Factors for Hospitalization in Adult Patients With Primary Immunodeficiency.

Allergy, asthma &amp; immunology research
2025

Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling.

Frontiers in genetics
2025

A Rare Co-occurrence of Duchenne Muscular Dystrophy and Glycerol Kinase Deficiency Associated With Xp21 Contiguous Gene Deletion Syndrome: A Case Report.

Cureus
2026

Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesis.

HemaSphere
2025

A Zebrafish Seizure Model of cblX Syndrome Reveals a Dose-Dependent Response to mTor Inhibition.

Journal of developmental biology
2025

Rare Dual Genetic Diagnosis of Wiskott-Aldrich Syndrome and Ghoshal Hematodiaphyseal Dysplasia: Clinical, Diagnostic, and Management Challenges.

Cureus
2026

Novel variants in STAG2 and PKD1 associate with multiple congenital malformations and autosomal dominant polycystic kidney disease in a Chinese family: A case report and literature review.

Experimental and therapeutic medicine
2026

Clinical features and genetic analysis of androgen receptor gene variants in 30 prepubertal patients with androgen insensitivity syndrome.

Asian journal of andrology
2026

Rapid flow cytometric diagnosis of XIAP deficiency.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2026

Generation of a male isogenic pair and a female isogenic pair(R83C) for studying NAA10-related syndrome as part of a large Ogden syndrome biobank.

Stem cell research
2026

MiR-874-3p suppresses TNF-α-induced inflammation in adipocytes by targeting nucleolin.

Journal of molecular histology
2025

Congenital Inborn Errors of Metabolism: Clinical and Imaging Pearls.

Radiographics : a review publication of the Radiological Society of North America, Inc
2026

Functional skills in MECP2 duplication syndrome: developmental dynamics and regression.

Orphanet journal of rare diseases
2026

Dynamic allele usage of X-linked genes ameliorates neurodevelopmental disease phenotypes in brain organoids.

Nature communications
2026

Orbital inflammation in VEXAS syndrome.

The British journal of ophthalmology
2026

Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review.

British journal of haematology
2026

VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.

Lancet (London, England)
2025

Coexistence of Alport Syndrome and Fabry Disease in a Female with R112H Variant: Early Progression of Fabry Nephropathy.

International journal of molecular sciences
2026

Thyrotoxicosis in MCT8 deficiency.

The Journal of clinical endocrinology and metabolism
2026

The missense mutation Y65C in PQBP1 causes microcephaly and cognitive deficits through a combination of partial loss-of-function and gain-of-function effects.

Nature communications
2026

When the kidneys speak for the brain: a nephrological presentation of a rare neurological disorder.

Pediatric nephrology (Berlin, Germany)
2025

A Case of VEXAS Syndrome.

WMJ : official publication of the State Medical Society of Wisconsin
2026

Morphologic Deciphering of Hematopoietic Cell Vacuolization: Lessons From VEXAS Syndrome and Other Etiologies.

International journal of laboratory hematology
2026

VEXAS Syndrome with Vibrio vulnificus Sepsis During Treatment with Tocilizumab: A Case Report.

Internal medicine (Tokyo, Japan)
2026

Whole-genome sequencing identified a deep intronic COL4A5 variant causing aberrant splicing in a female patient with X-linked Alport syndrome.

CEN case reports
2026

A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report.

The American journal of case reports
2026

Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE.

Nature biotechnology
2025

Melnick-Needles Syndrome: Synthesizing Current Knowledge on Etiology, Clinical Presentation, Diagnostic Methods, and Potential Therapeutic Options.

Prague medical report
2026

Dual-Genetic Etiology in an Atypical Dent Disease Phenotype Which Combines Features of Focal Segmental Glomerulosclerosis and Ellis-Van Creveld-Like Syndrome: A Case Report.

Case reports in nephrology and dialysis
2025

Glycogen storage disorder-mimicking presentation of X-linked lymphoproliferative syndrome (XLP).

BMJ case reports
2025

Biochemical evaluation of X-linked hypophosphatemia and tumor-induced osteomalacia: insights into diagnosis and management.

Frontiers in endocrinology
2025

A Family with Meester-Loeys Syndrome Caused by a Novel Missense Variant in the BGN Gene.

International journal of molecular sciences
2025

A Rare Case of Mild Hemophilia A in a Female with Mosaic Monosomy X and a De Novo F8 Variant.

International journal of molecular sciences
2025

Genetic, Clinical and Neuroradiological Spectrum of MED-Related Disorders: An Updated Review.

Genes
2025

Identification of a Novel Nonsense Mutation in the IGSF1 Gene Reveals Sex-Specific Phenotypic Variability Within a Single Family.

Children (Basel, Switzerland)
2025

An Atypical Female Case of Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome with Severe Lower Limb Contractures Requiring Orthopedic Surgery.

Clinical, cosmetic and investigational dermatology
2026

Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice.

Human gene therapy
2026

Immunoglobulin disorders in pediatric chronic rhinosinusitis.

Current opinion in allergy and clinical immunology
2025

[Clinical and genetic analysis of a child with X-linked Hoyeraal-Hreidarsson syndrome due to variant of DKC1 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge.

Infection and drug resistance
2025

Case Report: Laparoscopic vaginoplasty in a case of partial androgen insensitivity syndrome and a literature review of 16 cases in China.

Frontiers in surgery
2025

A Vexing Diagnosis: ENT Presentation of Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome.

Cureus
2025

Case of a Male Patient With Focal Dermal Hypoplasia (Goltz Syndrome), Esophageal Polyps, Scoliosis, and Bicuspid Aortic Valve.

Cureus
2025

A case and review of fibroblast growth factor-23-mediated hypophosphatemic osteomalacia in the absence of pathogenic PHEX variants.

JBMR plus
2025

Two cases of TBL1XR1 heterozygous variants in children: a new splicing site variant identification and functional analysis through molecular docking and molecular dynamics simulation.

Human genomics
2025

Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters.

Cells
2025

MCT8 Deficiency in Two Brothers With a Novel Deletion Mutation in SLC16A2.

Case reports in genetics
2026

Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study.

Rheumatology (Oxford, England)
2026

New multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases.

Journal of lipid research
2025

Impact of Age-3 Urine Screening on Diagnosis and Treatment Timing in Alport Syndrome.

Kidney international reports
2025

Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome.

Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
2026

Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.

Clinical immunology (Orlando, Fla.)
2025

Anticodon-edited tRNA enables translational readthrough of COL4A5 premature termination codons.

PloS one
2025

Umbilical Cord Blood Transplantation in Lesch-Nyhan Syndrome: A Case Report and Literature Review.

Cureus
2026

Splice modulation of COL4A5 reinstates collagen IV assembly in an organoid model of Alport syndrome.

JCI insight
2025

VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east Italy.

Frontiers in immunology
2025

Uncovering Proteomic and Biochemical Alterations in Plasma from Lesch-Nyhan Disease Patients.

Cellular and molecular neurobiology
2025

Clinical features of hearing loss and genotype-phenotype correlations in Alport syndrome caused by COL4A4 or COL4A5 variants.

Scientific reports
2025

Case Report: VEXAS syndrome with extensive pulmonary, cardiac, and skeletal involvement.

Frontiers in immunology
2025

Gene Editing in Cardiac Disease: A Review of the Literature.

Cardiology in review
2025

MeCP2 regulates telencephalic development in human cerebral organoids.

Cell reports
2026

Functional evaluation of NAA10 variants in patients with Ogden syndrome.

Psychiatric genetics
2025

Concomitant Mosaic Turner Syndrome and Congenital Adrenal Hyperplasia in 1 of 3 Patients of USP9X Variant-Associated Autism Spectrum Disorder.

Molecular syndromology
2025

Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.

Frontiers in endocrinology
2025

Heterogeneity of Primary Ciliary Dyskinesia Gene Variants: A Genetic Database Analysis in Russia.

International journal of molecular sciences
2025

Misdiagnosis of 99mTc-PYP-positive Danon disease as ATTR-CA: a case report and molecular imaging pitfalls.

BMC cardiovascular disorders
2026

Doublecortin-expressing cells are selectively altered in the piriform cortex but not in neurogenic areas of symptomatic Mecp2-heterozygous mice.

Neuroscience
2025

Mitochondrial structure and function in OCRL depleted cells.

Frontiers in cell and developmental biology
2025

NDPACX: a newly defined X-linked Parkinsonian syndrome associated with SLC9A6 hemizygote mutation.

Brain communications
2026

PIGA variants are associated with focal epilepsy with favorable outcome and the sub-molecular effect.

Seizure
2026

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.

Blood advances
2025

Comprehensive clinical and immunologic characterization of Wiskott-Aldrich syndrome in Iran: a 10-year cohort study.

BMC immunology
2026

Female Patients With Mucopolysaccharidosis II (MPS II): Insights From the Hunter Outcome Survey.

JIMD reports
2026

Elamipretide: First Approval.

Drugs
2025

Mecp2 deficiency induces dysphagia in a preclinical model of Rett Syndrome.

bioRxiv : the preprint server for biology
2026

Simpson-Golabi-Behmel Syndrome Associated With a Missense Variant at the Signal Peptide Cleavage Site of GPC3.

American journal of medical genetics. Part A
2025

Capsaicin camphor and caffeic acid reduce adipogenesis and promote lipolysis with TRPV1 involvement.

Scientific reports
2025

Targeted fetal NGS panel reveals genetic conditions in sonographically normal fetuses: Insights from a large cohort study.

PloS one
2025

From Caudal Regression to Wieacker-Wolff Syndrome: The Decisive Role of Postmortem Examination and Exome Sequencing in Revising a Prenatal Diagnosis.

Cureus
2025

Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults: An Evolving Landscape.

Neurology. Genetics
2025

Albinism: from genetics to cell biology and physiopathology.

Presse medicale (Paris, France : 1983)
2025

Impaired cortical development and translational control in a missense mouse model of DDX3X syndrome.

Disease models &amp; mechanisms
2025

Whole-Exome Sequencing Identified a Nonsense Pathogenic Variant in the MITF Gene Associated with Non-syndromic Hearing Loss.

Biochemical genetics
2025

VEXAS syndrome with eosinophilia and pathologically mimicking histiocytosis: a case report.

Modern rheumatology case reports
2025

Case Report: A novel TTN gene variant and a concurrent rare COL4A4 gene variant in a Chinese patient with dilated cardiomyopathy.

Frontiers in cardiovascular medicine
2025

A Novel STAG2 Frameshift Variant in Mullegama-Klein-Martinez Syndrome with Complex Conotruncal Heart Defect.

Genes
2026

Congenital adrenal hypoplasia with neurodevelopmental delay due to contiguous Xp21 deletion: a case series with review of literature.

Endocrine journal
2026

A cytoplasmic clue in a man with febrile illness: VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.

The British journal of dermatology
2025

Deficient Cardiolipin Remodeling Alters Muscle Fiber Composition and Neuromuscular Connectivity in Barth Syndrome.

bioRxiv : the preprint server for biology
2025

Long-read sequencing reveals extensive FMR1 somatic mosaicism in Fragile-X associated tremor/ataxia syndrome in human brain.

bioRxiv : the preprint server for biology
2025

Monitoring Variant Allele Fraction in VEXAS Syndrome: A Comparison of Digital PCR and Next-Generation Sequencing.

EJHaem
2025

Clinical variation in Lowe syndrome: what and how?

Frontiers in cell and developmental biology
2025

Real-world disease burden and health care resource utilization for patients with Barth syndrome.

Journal of medical economics
2025

Epidemiology and Healthcare Resource Utilization of Rett Syndrome in Canada: The Ontario Experience.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2025

Evaluation and follow-up of newborns screening positive for mucopolysaccharidosis II: Results from an international modified Delphi consensus.

Molecular genetics and metabolism
2026

Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval.

Drug discoveries &amp; therapeutics
2026

Longitudinal Characterization of Males With X-Linked Creatine Transporter Deficiency: Final Results of a Multiyear Observational Study.

Pediatric neurology
2025

Gastrointestinal symptoms in adults with Fabry disease and their associations with physical and mental health.

BMC gastroenterology
2025

Autosomal Dominant Alport Syndrome Diagnosed in an Elderly Man.

Cureus
2025

Monogenic defects in Russian children with autism spectrum disorders.

World journal of clinical pediatrics
2025

Atypical case of Rett syndrome with concurrent MECP2 gene mutation and del(15)(q22qter) karyotype: A case report and review of literature.

World journal of clinical pediatrics
2025

Cardiovascular Collapse During Scoliosis Surgery in a Patient With Coffin-Lowry Syndrome and Mesocardia.

Cureus
2026

[Endothelial dystrophies and degenerations of the cornea].

Klinische Monatsblatter fur Augenheilkunde
2025

Unravelling the Puzzle: Highlighting a Case of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Mimicker Presented With Inflammatory Symptoms and Pancytopenia.

Cureus
2026

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome.

Pediatric nephrology (Berlin, Germany)
2026

Prominent U-waves without QT prolongation in X-linked creatine transporter deficiency caused by SLC6A8 variants.

Heart rhythm
2025

A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.

Molecular biology reports

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de parkinsonismo – espasticidade, ligada ao cromossomo X.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de parkinsonismo – espasticidade, ligada ao cromossomo X

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Second allogeneic stem cell transplantation for XMEN disease.
    BMJ case reports· 2026· PMID 41871900mais citado
  2. Systematic reassessment of reported variants in individuals with suspicion of Alport spectrum disorder reveals a high rate of ambiguous results.
    European journal of human genetics : EJHG· 2026· PMID 41851263mais citado
  3. Disturbed mitochondrial maturation in cardiolipin remodeling-deficient cardiomyocytes.
    iScience· 2026· PMID 41847620mais citado
  4. Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.
    Molecular therapy : the journal of the American Society of Gene Therapy· 2026· PMID 41832599mais citado
  5. Cerebellar hypoplasia caused by CASK deficiency.
    Molecules and cells· 2026· PMID 41831576mais citado
  6. Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study.
    Rheumatology (Oxford)· 2026· PMID 41437650recente
  7. A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.
    Mol Biol Rep· 2025· PMID 41240171recente
  8. Periorbital oedema, trismus, myalgia as muscular manifestations of VEXAS syndrome: a case report and narrative literature review.
    Rheumatology (Oxford)· 2026· PMID 41056436recente
  9. [VEXAS syndrome].
    Z Rheumatol· 2025· PMID 40960635recente
  10. [Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].
    Rev Med Interne· 2026· PMID 40945967recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:363654(Orphanet)
  2. OMIM OMIM:300911(OMIM)
  3. MONDO:0010482(MONDO)
  4. Distonia e Espasticidade(PCDT · Ministério da Saúde)
  5. GARD:17567(GARD (NIH))
  6. Variantes catalogadas(ClinVar)
  7. Busca completa no PubMed(PubMed)
  8. Q55782498(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de parkinsonismo – espasticidade, ligada ao cromossomo X
Compêndio · Raras BR

Síndrome de parkinsonismo – espasticidade, ligada ao cromossomo X

ORPHA:363654 · MONDO:0010482
🇧🇷 Brasil SUS
Geral
Prevalência
<1 / 1 000 000
Casos
5 casos conhecidos
Herança
X-linked recessive
CID-10
G20 · Doença de Parkinson
Início
Adolescent, Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C3806722
Repurposing
2 candidatos
procyclidineacetylcholine receptor antagonist
trihexyphenidyl
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades